|
US2005125851A1
|
|
Methods of diagnosis and treatment of interstitial lung disease
|
|
WO03004706A1
|
|
Glucocorticoid-induced receptor and methods of use
|
|
WO02101012A2
|
|
Regulation of transgene expression following aav transduction
|
|
WO02064842A2
|
|
Quantitative epstein barr virus pcr rapid assay
|
|
WO0179506A2
|
|
Treatment of ocular neovascularization and related diseases
|
|
US6812340B2
|
|
Inhibition of bone tumor formation using antisense cDNA therapy
|
|
US6872406B2
|
|
Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
|
|
WO0156596A1
|
|
Use of lysosomal acid lipase for treating atherosclerosis and related diseases
|
|
WO0154679A2
|
|
Transdermal composition containing an anesthetic and a vasodilator agent
|
|
CA2366838A1
|
|
A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
|
